Ocaliva® is authorized for the Treatment of primary biliary Cholangitis

被引：0

|

作者：

Langenbacher, Diane

机构：

来源：

VISCERAL MEDICINE | 2017年 / 33卷 / 01期

关键词：

D O I：

暂无

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

引用

收藏

页码：93 / 93

页数：1

相关论文

共 50 条

[1] Obeticholic Acid (Ocaliva) for Primary Biliary Cholangitis
不详
[J]. MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2017, 59 (1517): : 53 - 55
[2] OCALIVA now contraindicated in advanced primary biliary cholangitis
[J]. Reactions Weekly, 2022, 1937 (1) : 9 - 9
[3] Real world experience of obeticholic acid (Ocaliva) for the treatment of primary biliary cholangitis in the secondary care setting
Pratt, Anthony
Turner, Lucy
Hutchinson, John
Maher, Laura
Orange, Dawn
Millson, Charles
[J]. JOURNAL OF HEPATOLOGY, 2019, 70 (01) : E405 - E406
[4] Primary biliary cholangitis: treatment
Cazzagon, Nora
Floreani, Annarosa
[J]. CURRENT OPINION IN GASTROENTEROLOGY, 2021, 37 (02) : 99 - 104
[5] Modern treatment of primary biliary cholangitis
Strassburg, C. P.
[J]. INTERNIST, 2018, 59 (01): : 105 - 112
[6] Diagnosis and Treatment of Primary Biliary Cholangitis
Kim, Kyung-Ah
[J]. KOREAN JOURNAL OF GASTROENTEROLOGY, 2023, 81 (02): : 86 - 90
[7] Diagnosis and treatment of primary biliary cholangitis
Laschtowitz, Alena
de Veer, Rozanne C.
van der Meer, Adriaan J.
Schramm, Christoph
[J]. UNITED EUROPEAN GASTROENTEROLOGY JOURNAL, 2020, 8 (06) : 667 - 674
[8] Obeticholic acid Approved indication: primary biliary cholangitis Ocaliva (Chiesi) 5 mg and 10 mg tablets
不详
[J]. AUSTRALIAN PRESCRIBER, 2020, 43 (05) : 174 - 175
[9] New Guidelines on primary biliary Cholangitis: Obeticholic Acid (Ocaliva®) considered as the only approved Second-line Therapy
不详
[J]. VISCERAL MEDICINE, 2017, 33 (05) : 392 - 392
[10] Obeticholic acid for the treatment of primary biliary cholangitis
Ali, Ahmad H.
Lindor, Keith D.
[J]. EXPERT OPINION ON PHARMACOTHERAPY, 2016, 17 (13) : 1809 - 1815

← 1 2 3 4 5 →